---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-212534"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2021-07-12T23:59:59+00:00"
generated_at: "2026-06-30T06:04:26.863451+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Tempest Therapeutics appoints Nicholas Maestas as VP, Strategy and Finance and PFO

## Summary
- Appointed Nicholas Maestas, age 41, as VP, Strategy and Finance and principal financial officer, effective July 12, 2021.
- Maestas previously served as head of FP&A and strategic finance at Alector, Inc. since 2019.
- Base salary of $325,000; eligible for annual performance bonus with target of 30% of base salary.
- Granted option to purchase 23,225 common shares at July 12 closing price; vests 25% at 1 year, then monthly over 48 months.
- Severance: 3 months salary/benefits outside change of control; 6 months salary plus 50% bonus and accelerated vesting during change of control.

## SEC filing metadata
- accession: 0001193125-21-212534
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2021-07-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000119312521212534/0001193125-21-212534-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000119312521212534/d181625d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-212534
- JSON: https://secwatch.observer/filing/0001193125-21-212534.json
- Plain text: https://secwatch.observer/filing/0001193125-21-212534.txt

## Key facts
- Executive change
  Nicholas Maestas was appointed as vice president, strategy and finance and principal financial officer at Tempest Therapeutics, Inc..
  - Action: appointed
  - Role: vice president, strategy and finance and principal financial officer
  source text: On July 12, 2021, Nicholas Maestas, age 41, joined Tempest Therapeutics, Inc. (the “Company”) as vice president, strategy and finance and is the Company’s principal financial officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312521212534/0001193125-21-212534-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.